ON March 25, 2024, Public Accounts Committee (PAC) chairman Datuk Mas Ermieyati Samsudin reported that the pharmaceutical company involved in the matter of defective ventilators sold to the Malaysian Government had agreed on a repayment of RM16.78mil to the Health Ministry (MOH). The company was originally paid RM30mil to acquire the equipment during the Covid-19 pandemic; the botched process ultimately resulted in RM13.07mil in losses and the underdelivery of the number of ventilators from a contracted 500 units to only 32 usable units.
The Center to Combat Corruption and Cronyism (C4 Center) covered this issue when it first arose, demanding accountability and reforms to the procurement process. We are relieved to see some action is being taken on this matter – but more must be done.
